EIC is thrilled to release an HIV rapid diagnostics test (RDT) market landscape report 2023 that for the first time takes a holistic look at the market. The report is a collaboration with the World Health Organisation and looks at HIV professional-use RDTs, HIV self-tests (HIVSTs), and dual HIV/Syphilis tests and provides an integrated forecast, technology review and market dynamics assessment. The report answers the question: From a market perspective, what could get in the way of achieving global HIV testing targets?

The market dynamics assessment covers key market trends, regulatory frameworks, competition and market challenges. Based on the identification of those key market challenges, the report provides actionable recommendations for stakeholders operating within the market informed by a diverse group of global health stakeholders who provided input into the report and forecast via a technical working group and from the joint WHO/UNAIDS Annual Health Commodity Forecasting meeting. “Against the backdrop of competing priorities, funding for testing in many settings has declined. We know that without testing we cannot treat and prevent infections, achieve global goals, sustain low HIV incidence, and save lives. This report offers a timely and comprehensive analysis of opportunities that can increase efficiencies in the RDT market,” said Dr Meg Doherty, Director, Global HIV, Hepatitis and STI Programmes.

We are confident that this report will be an invaluable resource for stakeholders in the HIV RDT Market, and we are happy to share it with you. We thank the WHO and all partners involved for their collaboration and contributions, especially those that have shared data, insights and reviews that make the report possible.

EIC HIV Market Landscape Report for Public Release